English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

Sino-UK Companies Announce TB Vaccine Partnership Deal

Oct. 16, 2011

UK based ImmunoBiology and Chinese LIBP, a Sinopharm subsidiary, announced on October 17, 2011 the signing of a cooperation agreement which will enable both companies to co-develop ImmBio’s proprietary T-BioVax vaccine for Tuberculosis (TB). Upon completion of successful clinical studies, they aim to first launch the TB vaccine in the Chinese market.